AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimcan MV 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Alicanto Drugs Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimcan MV 1mg/500mg/0.2mg Tablet

Diabetic patients using Glimcan MV (1mg/500mg/0.2mg) tablets, an anti-diabetic combination medication, should adhere to the prescribed dosage and regimen. This medication manages blood glucose in adult type 2 diabetics. Always take it with food, consistently at the same time daily for optimal effectiveness. Dosage adjustments may occur based on blood glucose monitoring and your doctor's assessment. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan involving diet, exercise, and weight management as recommended by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (sugary foods or juice) are essential. Alcohol consumption should be limited due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Glimcan MV 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Glimcan MV 1mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimcan MV 1mg/500mg/0.2mg tablet whole; do not break, crush, or chew it. Administer on an empty stomach.

Common Side effects of Glimcan MV 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimcan MV 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Glimcan MV 1mg/500mg/0.2mg tablets should be administered on an empty stomach.

How Glimcan MV 1mg/500mg/0.2mg Tablet works:

Each Glimcan MV tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Glimcan MV 1mg/500mg/0.2mg tablets is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimcan MV 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Seek medical advice before taking this medicine.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimcan MV 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Glimcan MV 1mg/500mg/0.2mg tablets is considered unsafe for individuals with kidney impairment and should be forgone. Patients with severe kidney disease should definitely not use this medication. A physician's consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Glimcan MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, it's contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimcan MV 1mg/500mg/0.2mg Tablet :

Should you forget to take your Glimcan MV 1mg/500mg/0.2mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimcan MV 1mg/500mg/0.2mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Diabetes medication

FAQs on Glimcan MV 1mg/500mg/0.2mg Tablet

Glimcan MV 1mg/500mg/0.2mg tablets contain glimepiride, metformin, and voglibose. This triple-drug formulation manages type 2 diabetes mellitus in adults, enhancing glycemic control when combined with a suitable diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar elevation. This medication is unsuitable for type 1 diabetes.
Taking Glimcan MV 1mg/500mg/0.2mg tablets may result in common adverse reactions such as low blood sugar, queasiness, loose stools, taste changes, gas, abdominal discomfort, headache, skin eruptions, and upper respiratory infections.
Patients with hypersensitivity to Glimcan MV 1mg/500mg/0.2mg Tablet constituents or inactive ingredients should not take this medication. Similarly, its administration is contraindicated in individuals with moderate to severe nephropathy, inflammatory bowel conditions, colonic ulcers, and metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol while taking Glimcan MV 1mg/500mg/0.2mg tablets is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Indeed, Glimcan MV 1mg/500mg/0.2mg Tablets may induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Retain this medication in its original, sealed packaging. Store as directed on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Glimcan MV 1mg/500mg/0.2m...
110
MRP 134
17% off